A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...

A leading hospital in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced cancer ...

Cancer therapy continues to evolve, with significant advances in precision techniques such as surgery, chemotherapy, immunotherapy, radiotherapy, and ...

Aga Khan University Hospital bets in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding ...

Skoltech researchers and their colleagues from KTH Royal Institute of Technology, Sweden, have created an important building ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancements in metastatic castration resistant ...

The findings, published in JAMA Network Open, were reported by Cristian Udovicich of the Odette Cancer Centre at Sunnybrook ...

Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

SHERBET, an individual patient data post hoc pooled analysis of 5 prospective trials, compared HDR-BT with SBRT in patients with intermediate-risk prostate cancer.

A pooled analysis of five prospective trials showed that stereotactic body radiotherapy (SBRT) was associated with a lower risk for biochemical failure over 10 years vs high-dose rate brachytherapy ...